BloodScan achieves near-100% capture of circulating tumor cells in stage IV breast, lung, pancreatic, and virtually all solid cancers—providing the most reliable tumor signal in advanced disease.
Our Labyrinth system uniquely identifies circulating tumor cells from the earliest stages—even in pre-invasive conditions such as DCIS and early HCC—reaching beyond the limits of traditional liquid biopsy.advanced disease.
BloodScan’s intact CTCs preserve real tumor biology, delivering tissue-equivalent genomic and treatment-relevant insights through a simple blood draw.disease.
